These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17355745

  • 1. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.
    Crouse JR, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS, METEOR Study Group.
    Curr Med Res Opin; 2007 Mar; 23(3):641-8. PubMed ID: 17355745
    [Abstract] [Full Text] [Related]

  • 2. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group.
    JAMA; 2007 Mar 28; 297(12):1344-53. PubMed ID: 17384434
    [Abstract] [Full Text] [Related]

  • 3. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
    Crouse JR, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS, METEOR Study Group.
    Eur J Cardiovasc Prev Rehabil; 2010 Apr 28; 17(2):223-9. PubMed ID: 20038840
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein lowering with rosuvastatin in the METEOR study.
    Peters SA, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Raichlen JS, Bots ML.
    J Intern Med; 2010 Aug 28; 268(2):155-61. PubMed ID: 20412373
    [Abstract] [Full Text] [Related]

  • 5. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
    Crouse JR, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS, Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group.
    Cardiovasc Drugs Ther; 2004 May 28; 18(3):231-8. PubMed ID: 15229392
    [Abstract] [Full Text] [Related]

  • 6. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.
    Dogan S, Plantinga Y, Crouse JR, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML, METEOR Study Group.
    J Hypertens; 2011 Nov 28; 29(11):2181-93. PubMed ID: 21918474
    [Abstract] [Full Text] [Related]

  • 7. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR, METEOR Study Group.
    J Intern Med; 2009 Jun 28; 265(6):698-707. PubMed ID: 19298496
    [Abstract] [Full Text] [Related]

  • 8. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.
    Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M.
    Am J Cardiol; 2009 Oct 01; 104(7):936-42. PubMed ID: 19766760
    [Abstract] [Full Text] [Related]

  • 9. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    Curr Med Res Opin; 2012 Jun 01; 28(6):891-9. PubMed ID: 22536884
    [Abstract] [Full Text] [Related]

  • 10. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G, Vitulano N, Mancini B, Zanasi A, D'Orazio N.
    Pharmacology; 2010 Jun 01; 85(2):63-7. PubMed ID: 20110750
    [Abstract] [Full Text] [Related]

  • 11. Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML, METEOR Study Group.
    J Intern Med; 2012 Mar 01; 271(3):247-56. PubMed ID: 21726301
    [Abstract] [Full Text] [Related]

  • 12. Reduction of intima-media thickness in subjects with asymptomatic carotid disease: two cases from the Asymptomatic Carotid Atherosclerosis DIsease Manfredonia Study (ACADIM Study).
    Riccioni G, D'Orazio N.
    Clin Ter; 2007 Mar 01; 158(5):431-3. PubMed ID: 18062350
    [Abstract] [Full Text] [Related]

  • 13. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Investigators.
    J Am Soc Echocardiogr; 2012 Jan 01; 25(1):91-100. PubMed ID: 21982737
    [Abstract] [Full Text] [Related]

  • 14. Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease.
    Fernández-Miranda C, Yebra M, Aranda JL, Gómez P, Martínez J, Núñez V, Gómez de la Cámara A.
    Int J Cardiol; 2007 Jun 12; 118(3):345-9. PubMed ID: 17052775
    [Abstract] [Full Text] [Related]

  • 15. Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study.
    Peters SA, Lind L, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen J, Bots ML, den Ruijter HM, METEOR study group.
    J Intern Med; 2012 Sep 12; 272(3):257-66. PubMed ID: 22172243
    [Abstract] [Full Text] [Related]

  • 16. Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults study.
    Oren A, Vos LE, Uiterwaal CS, Gorissen WH, Grobbee DE, Bots ML.
    Int J Obes Relat Metab Disord; 2003 Nov 12; 27(11):1383-90. PubMed ID: 14574350
    [Abstract] [Full Text] [Related]

  • 17. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group.
    Circ Cardiovasc Qual Outcomes; 2009 Nov 12; 2(6):616-23. PubMed ID: 20031900
    [Abstract] [Full Text] [Related]

  • 18. METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.
    Haddad RM, Ballantyne CM.
    Phys Sportsmed; 2010 Jun 12; 38(2):180-2. PubMed ID: 20631478
    [Abstract] [Full Text] [Related]

  • 19. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R, Kondos GT, Perez A, Chen Z, Mazzone T.
    Circulation; 2008 Apr 22; 117(16):2123-30. PubMed ID: 18413496
    [Abstract] [Full Text] [Related]

  • 20. Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease.
    Maki KC, Davidson MH, Dicklin MR, Bell M, Witchger M, Feinstein SB.
    J Clin Lipidol; 2011 Apr 22; 5(3):141-151. PubMed ID: 21600518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.